dc.description.sponsorship | The EPIC study has been supported by the Europe Against Cancer Program of the European Commission (SANCO); Deutsche Krebshilfe; Deutsches Krebsforschungszentrum; German Federal Ministry of Education and Research; Danish Cancer Society; Health Research Fund (FIS) of the Spanish Ministry of Health; Spanish Regional Governments of Andalucia, Asturias, Basque Country, Murcia and Navarra; Catalan Institute of Oncology, Spain; the ISCIII of the Spanish Ministry of Health (RETICC DR06/0020); Cancer Research UK; Medical Research Council, United Kingdom; Greek Ministry of Health; Stavros Niarchos Foundation; Hellenic Health Foundation; Italian Association for Research on Cancer (AIRC); Italian National Research Council; Fondazione-Istituto Banco Napoli, Italy; Associazione Italiana per la Ricerca sul CancroAIRC-Milan; Compagnia di San Paolo; Dutch Ministry of Public Health, Welfare and Sports; World Cancer Research Fund; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Västerbotten, Sweden; NordForsk (Centre of excellence programme HELGA), Norway; French League against Cancer (LNCC), France; National Institute for Health and Medical Research (INSERM), France; Mutuelle Générale de l’Education Nationale (MGEN), France; 3M Co, France; Gustave Roussy Institute (IGR), France; and General Councils of France | |
dc.description.statementofresponsibility | Fanidi, A., Muller, D.C., Midttun, Ø., Ueland, P.M., Vollset, S.E., Relton, C., Vineis, P., Weiderpass, E., Skeie, G., Brustad, M., Palli, D., Tumino, R., Grioni, S., Sacerdote, C., Bueno-De-Mesquita, H.B., Peeters, P.H., Boutron-Ruault, M.-C., Kvaskoff, M., Cadeau, C., Huerta, J.M., Sánchez, M.-J., Agudo, A., Lasheras, C., Quirós, J.R., Chamosa, S., Riboli, E., Travis, R.C., Ward, H., Murphy, N., Khaw, K.-T., Trichopoulou, A., Lagiou, P., Papatesta, E.-M., Boeing, H., Kuehn, T., Katzke, V., Steffen, A., Johansson, A., Brennan, P., Johansson, M. | |